Skip to main content
OrganiGram Holdings Inc. (OGI)
NASDAQ: OGI · IEX Real-Time Price · USD
1.650
+0.030 (1.85%)
At close: Jul 19, 2024, 12:00 AM
1.710
+0.060 (3.64%)
Pre-market: Jul 22, 2024, 9:11 AM EDT

OrganiGram Holdings Revenue

Revenue in the quarter ending March 31, 2024 was $27.67M. In the fiscal year ending September 30, 2023, OrganiGram Holdings had annual revenue of $119.73M with 6.75% growth.

Revenue (ttm)
$119.73M
Revenue Growth
+6.75%
P/S Ratio
n/a
Revenue / Employee
$121,679
Employees
984
Market Cap
170.56M USD

Revenue Chart

* The company reports in CAD currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Sep 30, 2023119.73M7.57M6.75%
Aug 31, 2022112.16M48.83M77.10%
Aug 31, 202163.33M-2.42M-3.69%
Aug 31, 202065.75M5.29M8.75%
Aug 31, 201960.46M51.04M542.11%
Aug 31, 20189.42M5.10M118.41%
Aug 31, 20174.31M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Puma Biotechnology 226.63M
Rigel Pharmaceuticals 120.35M
Repare Therapeutics 97.86M
Innate Pharma 68.49M
Fennec Pharmaceuticals 44.95M
MediWound 19.85M
Syros Pharmaceuticals 6.98M
Revenue Rankings

OGI News

More News